Suppositories Dose Form

Trust Your Suppository Dosage Form to LGM Pharma’s Experts

Producing 35 million doses annually, LGM Pharma is a leader in suppositories manufacturing

Niche among the semi-solid category of pharmaceutical dosage forms, suppositories require expert knowledge and skill to formulate, develop, and manufacture. Because the active pharmaceutical ingredient (API) penetrates mucosal membranes of the vagina or rectum, suppositories must be gentle and non-irritating, stable until inserted, and dissolve to deliver therapeutic relief.

LGM Pharma has invested in the personnel, technologies, and equipment to formulate, manufacture, and package, under GMP standards, more than 35 million suppository doses annually.

Specialists in Pharmaceutical Suppositories

Suppository formulation, development, and manufacturing is LGM Pharma’s forte:

  • Vaginal and rectal suppositories
  • Generic and innovator
  • Prescription and over-the-counter
  • Suppository doses: 0.5 – 3.0 g
  • Typical commercial batch sizes: 100 – 1,800 kg
    • Clinical trial materials and kitting
  • Production equipment includes fully automated, high-speed Sarong SAAS 6 form, fill, seal, and carton technology
  • Packaging options include PVC/PE film, in-house film printing, and multiple configurations to meet individual customer needs
  • Track and trace capabilities planned for late 2022

We formulate, develop, test, manufacture, and package suppositories at our 54,000-square-foot facility in Rosenberg, Texas. This state-of-the-art facility is fully licensed and accredited for GMP manufacturing. FDA inspections and annual customer audits reveal no current issues or observations.

Quality by Design Practices

Long before the FDA established Quality by Design practices, LGM Pharma bred quality into the development of its manufacturing and production processes. Whether we formulate your suppository dosage form or transfer it in, we develop, validate, and enforce strict manufacturing protocols. We ensure Critical Quality Attributes are maintained for a reproducibly safe, efficacious, and stable finished product.

Full-Service Capabilities

From securing high-quality active pharmaceutical ingredients (API) to manufacturing finished drug product, LGM Pharma can bring your suppository formulation to market. In-house analytical testing services are also part of your CDMO engagement.

End-to-end capability in our U.S.-based facilities is particularly valuable if you’re looking to reshore your drug manufacturing or to reformulate, for example, under the 505(b)(2) pathway.

Cbox partnersmart - lgm pharma

Partner Smart

Unique Outsourcing Models

At LGM Pharma, you’re more than a customer. We’re partners – and successful partnerships have “win-win” outcomes. That’s why we offer standard fee-for-service packages, joint-venture partnerships, and risk/profit-sharing models.

Explore Partnership Models

Looking to bring a niche suppository to market? Trust LGM Pharma for end-to-end services that take you from formulation to market. We have 35 million suppositories annually to prove that.